Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Bo-Gun Kho"'
Publikováno v:
IEEE Access, Vol 12, Pp 117176-117202 (2024)
Early identification of patients’ clinical status plays a critical role in intensive care unit (ICU) care. The increased adoption of electronic health records (EHRs) in the ICU creates prospects for deep learning (DL) application systems in this di
Externí odkaz:
https://doaj.org/article/17a637c20d15446dae5893728bb18a43
Autor:
Hwa Kyung Park, Chang-Seok Yoon, Young-Ok Na, Jae-Kyeong Lee, Hyung-Joo Oh, Ha-Young Park, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yong-Soo Kwon, In-Jae Oh, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Cheol-Kyu Park
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract In this study, we aimed to investigate the feasibility of serum Krebs von den Lungen-6 (KL-6) as a potential biomarker for treatment-related ILD (TR-ILD) in lung cancer. We recruited patients with lung cancer in whom KL-6 was measured to dif
Externí odkaz:
https://doaj.org/article/81c90ec2cb2041d2941724abec98063b
Publikováno v:
IEEE Access, Vol 11, Pp 29091-29100 (2023)
In-hospital clinical deterioration is a major worldwide healthcare burden in the intensive care units (ICUs), as it requires rapid intervention. Rapid response systems (RRSs) are widely used in many hospitals for the early detection of clinical deter
Externí odkaz:
https://doaj.org/article/3e01033df3e648d7b9ecc8f910357511
Autor:
Chang-Seok Yoon, Hwa-Kyung Park, Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yong-Soo Kwon
Publikováno v:
Respiratory Medicine Case Reports, Vol 43, Iss , Pp 101844- (2023)
Nontuberculous mycobacteria (NTM) are ubiquitous organisms, but can cause a chronic pulmonary infection in some patients. Therefore, there could be host factors susceptible to this disease. A structural lung disease including damages of lungs caused
Externí odkaz:
https://doaj.org/article/bcc8307f71fa4838b7a52c325d72fe0d
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 408-414 (2020)
Background We correlated the tumor proportion score (TPS) of programmed cell death ligand 1 (PD‐L1, SP263 or 22C3) expression with the disease control rate (DCR, partial remission and stable disease), and progression free survival (PFS) after nivol
Externí odkaz:
https://doaj.org/article/690f44dadc42418393746142255856f0
Autor:
Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hyung-Joo Oh, Cheol-Kyu Park, In-Jae Oh, Young-Chul Kim, Ha-Young Park
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278610 (2022)
ObjectivePulmonary arteriovenous malformation (PAVM) is a rare pulmonary disease. Although most patients with PAVMs are asymptomatic, cerebral complications associated with PAVMs are often fatal. This study aimed to evaluate the risk factors for cere
Externí odkaz:
https://doaj.org/article/433d86e5fb6d4eec88b60702767dc6fc
Autor:
Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yu-Il Kim, Sung-Chul Lim, Yoo-Duk Choi, Yong-Soo Kwon
Publikováno v:
Respiratory Medicine Case Reports, Vol 40, Iss , Pp 101759- (2022)
Tracheal tumors are rare diseases. They can cause narrowing of a central airway, a severe respiratory distress, and death. The objective of this case series is to highlight the role of rigid bronchoscopy in diagnosing and treating carina masses which
Externí odkaz:
https://doaj.org/article/aba4053adb8f4b34a2c7d53608614957
Autor:
Je‐Seong Kim, Tai‐Seung Nam, Jieun Kim, Bo‐Gun Kho, Cheol‐Kyu Park, In‐Jae Oh, Young‐Chul Kim
Publikováno v:
Thoracic Cancer, Vol 10, Iss 10, Pp 2045-2049 (2019)
Here, we report a case of myasthenia gravis and myopathy in a patient treated with nivolumab. A 76‐year‐old man who had been treated with four doses of nivolumab because of non‐small cell lung cancer (NSCLC) presented with proximal‐dominant m
Externí odkaz:
https://doaj.org/article/0be3e09b407e4cd484b97c0ff8e47b7e
Autor:
Ki-Jeong Park, Tae-Ok Kim, Young-Nan Cho, Hye-Mi Jin, Young-Goun Jo, Hong-Joon Shin, Bo Gun Kho, Seung-Jung Kee, Yong-Wook Park
Publikováno v:
Frontiers in Immunology; 2024, p1-14, 14p
Autor:
Hayoung Choi, Jae‐Kyeong Lee, Hyung‐Joo Oh, Min‐Seok Kim, Bo Gun Kho, Cheol Kyu Park, In‐Jae Oh, Young‐Chul Kim
Publikováno v:
Thoracic Cancer, Vol 12, Iss 10, Pp 1598-1604 (2021)
Abstract Background We report a subgroup analysis of afatinib with respect to its efficacy, safety, and the long‐term survival of patients in a Named Patient Use program at a single institution. Methods We analyzed 60 patients with stage IV non‐s
Externí odkaz:
https://doaj.org/article/161e737b482448f1998a152546d9e9f2